140 related articles for article (PubMed ID: 7839075)
1. Prevalence of antihuman parvovirus B19 IgG antibodies in patients with refractory rheumatoid arthritis and polyarticular juvenile rheumatoid arthritis.
Mimori A; Misaki Y; Hachiya T; Ito K; Kano S
Rheumatol Int; 1994; 14(3):87-90. PubMed ID: 7839075
[TBL] [Abstract][Full Text] [Related]
2. Raised IgM antibodies to parvovirus B19 in juvenile rheumatoid arthritis.
Kishore J; Misra R; Gupta D; Ayyagari A
Indian J Med Res; 1998 Jan; 107():15-8. PubMed ID: 9529776
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
[TBL] [Abstract][Full Text] [Related]
4. Anti-human parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis.
Tzang BS; Tsai CC; Tsay GJ; Wang M; Sun YS; Hsu TC
Clin Chim Acta; 2009 Jul; 405(1-2):76-82. PubMed ID: 19362081
[TBL] [Abstract][Full Text] [Related]
5. Use of exploratory factor analysis to ascertain the correlation between the activities of rheumatoid arthritis and infection by human parvovirus B19.
Kakurina N; Kadisa A; Lejnieks A; Mikazane H; Kozireva S; Murovska M
Medicina (Kaunas); 2015; 51(1):18-24. PubMed ID: 25744771
[TBL] [Abstract][Full Text] [Related]
6. Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis.
Oğuz F; Akdeniz C; Unüvar E; Küçükbasmaci O; Sidal M
J Paediatr Child Health; 2002 Aug; 38(4):358-62. PubMed ID: 12173996
[TBL] [Abstract][Full Text] [Related]
7. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19 infection modulates the levels of cytokines in the plasma of rheumatoid arthritis patients.
Naciute M; Mieliauskaite D; Rugiene R; Maciunaite G; Mauricas M; Murovska M; Girkontaite I
Cytokine; 2017 Aug; 96():41-48. PubMed ID: 28288327
[TBL] [Abstract][Full Text] [Related]
9. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis.
Kozireva SV; Zestkova JV; Mikazane HJ; Kadisa AL; Kakurina NA; Lejnieks AA; Danilane IN; Murovska MF
J Rheumatol; 2008 Jul; 35(7):1265-70. PubMed ID: 18484700
[TBL] [Abstract][Full Text] [Related]
10. Different patterns of disease manifestations of parvovirus B19-associated reactive juvenile arthritis and the induction of antiphospholipid-antibodies.
Lehmann HW; Plentz A; von Landenberg P; Küster RM; Modrow S
Clin Rheumatol; 2008 Mar; 27(3):333-8. PubMed ID: 17851708
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of IgM-, IgA- and IgG-rheumatoid factors in seronegative polyarticular disease compared to pauciarticular disease in juvenile chronic arthritis as measured by ELISA.
Varbanova BB; Baleva M; Nikolov K; Mihailova D
Adv Exp Med Biol; 1999; 455():61-8. PubMed ID: 10599324
[TBL] [Abstract][Full Text] [Related]
12. Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study.
Varache S; Narbonne V; Jousse-Joulin S; Guennoc X; Dougados M; Daurès JP; Devauchelle-Pensec V; Saraux A
Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1565-70. PubMed ID: 21954118
[TBL] [Abstract][Full Text] [Related]
13. Human parvovirus B19 and rheumatoid arthritis.
Taylor HG; Borg AA; Dawes PT
Clin Rheumatol; 1992 Dec; 11(4):548-50. PubMed ID: 1486749
[TBL] [Abstract][Full Text] [Related]
14. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis.
Weissbrich B; Süss-Fröhlich Y; Girschick HJ
Arthritis Res Ther; 2007; 9(4):R82. PubMed ID: 17760961
[TBL] [Abstract][Full Text] [Related]
16. Frequency of antiparvovirus B19 antibodies in rheumatoid arthritis and systemic lupus erythematosus.
da Silva CP; Rêgo J; Barbosa Vde S; Cruz VA; da Silva NA
Rev Bras Reumatol; 2014; 54(1):21-6. PubMed ID: 24878787
[TBL] [Abstract][Full Text] [Related]
17. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan.
Chen YS; Chou PH; Li SN; Tsai WC; Lin KH; Tsai KB; Yen JH; Liu HW
J Rheumatol; 2006 May; 33(5):887-91. PubMed ID: 16511938
[TBL] [Abstract][Full Text] [Related]
18. Human Parvovirus B19 Infection in Rheumatoid Arthritis Patients: Screening and Clinical Significance.
Aboelazm AA; Emam SM; Elolemy GG; Fawzy RM
Egypt J Immunol; 2018 Jun; 25(2):1-10. PubMed ID: 30600943
[TBL] [Abstract][Full Text] [Related]
19. Human parvovirus B19-associated arthritis in children.
Nocton JJ; Miller LC; Tucker LB; Schaller JG
J Pediatr; 1993 Feb; 122(2):186-90. PubMed ID: 8429430
[TBL] [Abstract][Full Text] [Related]
20. The relationship between arthritis and human parvovirus B19 infection.
Caliskan R; Masatlioglu S; Aslan M; Altun S; Saribas S; Ergin S; Uckan E; Koksal V; Oz V; Altas K; Fresko I; Kocazeybek B
Rheumatol Int; 2005 Nov; 26(1):7-11. PubMed ID: 15322815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]